SINGAPORE, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that the Company bought back one million shares of its stock on the open market at an average price of $0.90 per share, in the period from August 28 to September 11, 2025. The buyback is the third buyback the Company has executed further to receiving shareholder and board approval for a share buyback of up to 20% of th ...

Recently initiated Phase 1b/2 multiple ascending dose study intended to assess safety and preliminary efficacy in nAMD patients receiving up to four initial monthly doses of TH103 Phase 1b/2 study to inform dose selection for potential Phase 3 development program, with initial data expected in 2H 2026 TH103’s ongoing Phase 1a single ascending dose study remains on track for data to be reported in Q4 2025 PALO ALTO, Calif., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Kalaris Therapeutics, Inc. (Nasdaq: KLRS) (“Kalari ...

JACKSONVILLE, Fla., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT) a provider of intelligent technologies and digital infrastructure solutions, today announced the appointment of Doug Recker as a Corporate Officer and President of the Company reporting to Chuck Ferry, Duos’ CEO. Mr. Recker, a seasoned telecommunications and data center executive with over 30 years of experience, has been a driving force behind Duos’ expansion into the Edge Data Cen ...

Accessibility StatementSkip Navigation To learn more about the event, visit www.virtualinvestorconferences.com. About Lipella Pharmaceuticals Inc.Lipella Pharmaceuticals is a clinical-stage biotechnology company focused on developing new drugs by reformulating active agents in existing generic drugs and optimizing these reformulations for new applications. Lipella targets diseases with significant unmet needs, where no approved drug therapies currently exist. The company completed its initial public offerin ...

Most seniors don’t realize there’s a clever financial maneuver that can shrink their tax bill in a big way. In fact, if you’re over a certain age, filing jointly with your partner, and meet the right conditions, you could earn as much as $141,900 tax-free in 2025. The strategy is called tax gain harvesting, and it could reshape your retirement plan. Must Read Tax gain harvesting Much like tax-loss harvesting, tax gain harvesting involves selling your assets strategically to lock in gains at lower tax r ...

Accessibility StatementSkip Navigation STAMFORD, Conn., Sept. 15, 2025 /PRNewswire/ -- Tronox Holdings plc (NYSE: TROX) ("Tronox" or the "Company"), today announced that Tronox Incorporated (the "Issuer"), a wholly owned subsidiary of the Company, intends to offer, subject to market and other considerations, senior secured notes due 2030 (the "Notes") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), ...

(Photo by Kevin Dietsch/Getty Images)Getty ImagesWith the Federal Reserve widely expected to cut rates by 0.25% at its September 16 meeting, attention is turning to where investors can find value in fixed income. Many default to the iShares Core U.S. Aggregate Bond ETF (AGG), which tracks the Bloomberg U.S. Aggregate Bond Index. But just as the S&P 500 captures only part of the equity universe, AGG represents a narrow slice of the bond market, often leaving higher-yielding and diversifying opportunities on ...

Acquisition significantly enhances the Company’s pipeline by adding novel assets in acute and chronic anticoagulation settingsCompany is strategically poised to deliver differentiated therapeutics across the spectrum of cardiovascular thrombotic risk PONTE VEDRA, Fla., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the gaps in anticoagulation therapy, today announced the acquisition of the assets o ...

If you like to see more ideas, please subscribe to the premium service "Value in Corporate Events" here and try the free trial. In this service we cover major earnings events, M&A, IPOs, and other significant corporate events with actionable ideas. Furthermore, we provide coverage of situations and names on request!Shares of Gemini Space Station (NASDAQ: GEMI ) have "of course" enjoyed a huge opening day gain, with crypto and blockchain being hugely in demand here, arguably being the second-hottest thing in ...

Vancouver, British Columbia – TheNewswire - September 15, 2025 - Majestic Gold Corp. (“Majestic” or the “Company”) (TSX.V: MJS, FSE: A0BK1D) reports that its safety production permit for the Songjiagou Underground Mine expired on September 11, 2025. Yantai Zhongjia Mining Co., Ltd. (“Yantai Zhongjia”), a subsidiary of the  Company, submitted all required application documents to the Shandong Provincial Emergency Management Department (“Emergency Department”) in August 2025 for renewal of the safety product ...